摘要
目的:探讨异欧前胡素对体外培养的人表皮黑素细胞酪氨酸酶和Rab27a的凋节作用。方法:体外分离人表皮黑素细胞并纯化培养,随机分为对照组和实验组。对照组加入M-254培养基,实验组加入含25μmol/L异欧前胡素的M-254培养基,培养48h后倒置显微镜下观察黑素细胞的形态;MTT法检测黑素细胞活力;Western blot法检测黑素细胞酪氨酸酶和转运相关蛋白Rab27a的表达;L-多巴氧化法和NaOH法测定黑素细胞酪氨酸酶活性和黑素含量。结果:与对照组比较,实验组人表皮黑素细胞的树状突起变长,黑素细胞活力降低17.2%(P<0.05),黑素细胞酪氨酸酶表达下降30.3%(P<0.01),而Rab27a表达升高31.9%(P<0.05);酪氨酸酶活性降低25.6%(P<0.05);黑素含量降低30.9%(P<0.01)。结论:25μmol/L异欧前胡素使黑素细胞的树状突起变长,抑制黑素细胞活力,抑制黑素细胞酪氨酸酶的表达和活性,促进黑素转运相关蛋白Rab27a的表达,降低黑素细胞中黑素的含量。
OBJECTIVE:To investigate the effects of isoimperaterin on regulation of tyrosinase and Rab27a in cultured human epidermal melanocytes. METHODS:Human epidermal melanocytes were isolated and cultured. The cells were randomly divided into control and experimental groups. Melanocytes of the control group were cultured with M-254 culture medium. Cells of the experimental group were cultured with M-254 culture medium containing 25 μmol/L isoimperaterin. The cells were cultured for 48 h and observed using inverted microscopy. Cell vitality was assayed using MTT method. The expression of tyrosinase and transfer-related protein Rab27a were analyzed by western blotting. The activity of tyrosinase and the content of melanin were measured by L-dopa oxidation and NaOH method,respectively. RESULTS:Compared with the control group,the dendrites of melanocytes of experimental group were elongated after treatment with 25 μmol/L isoimperaterin for 48 h. Melanocyte vitality was reduced by 17.2% (P〈0.05). Expression of tyrosinase was decreased by 30.3% (P〈0.01) and Rab27a was increased by 31.9% (P〈0.05). The activity of tyrosinase was reduced by 25.6% (P〈0.05). Melanin content was decreased by 30.9% (P〈0.01). CONCLUSION:25 μmol/L isoimperaterin elongated melanocytic dendrites but inhibited melanocyte vitality. It also inhibited the expression and activity of tyrosinase and promoted the expression of transfer-related protein Rab27a to reduce the content of melanin in cultured human epidermal melanocytes.
出处
《癌变.畸变.突变》
CAS
CSCD
2018年第1期37-41,共5页
Carcinogenesis,Teratogenesis & Mutagenesis
基金
广东省中医药局项目(20142082)